Background and Challenges
Our client, a global pharmaceutical company developing treatments across multiple therapeutic areas, requested an assessment of its global GxP Quality Management System. The goal was to identify discrepancies between global policies and their local implementation across regions.
Arithmos has supported multiple clients with QMS assessment and improvement projects in recent years. This case study highlights one example of a recent global GxP QMS assessment delivered on behalf of a client.
What are the difficulties with QMS oversight for global companies?
Global pharmaceutical companies face significant challenges in overseeing Quality Management Systems (QMS) due to the complexity of multinational operations and evolving regulatory requirements. Fragmented systems, varying standards, and resource constraints often create compliance gaps and inefficiencies.
Regulatory complexity
Diverse standards from agencies such as the FDA, EMA, and WHO create overlapping requirements that evolve frequently, making consistent oversight difficult across borders. Multinational organizations must align expectations across GCP, GVP, GMP, GDP, and ISO standards—where compliance in one region may not fully align with another.
Fragmented systems
Siloed QMS tools across global and local sites disrupt traceability and real-time data flow, increasing risks of non-compliance or product quality issues. Legacy platforms often lack interoperability, complicating end-to-end lifecycle management and limiting future system optimization (including potential AI integration). In addition, acquisitions and mergers frequently introduce complex quality-system integration challenges.
Resource and integration issues
High implementation costs, resistance to change, and limited internal expertise can strain global oversight—particularly when integrating legacy systems or acquired processes. Data integrity may be impacted by inconsistent records, while cross-functional collaboration suffers due to limited internal connectivity.
Our Approach
Arithmos allocated experienced GXP quality assurance and auditors to perform the assessment of the Global Quality QMS of the client. The following steps were taken to ensure the assessment effectively reach the target:
- Strategic pre-audit planning: we liaised with the client’s SMEs to ensure that interviews with subject matter experts were scheduled at appropriate times to accommodate the time zone in which each member of staff operated.
- Detailed assessment plan: we created a comprehensive plan outlining the scope of the assessment which was agreed with the client. The agenda included opening and closing meetings, interviews with key staff, and review of selected processes and company related records demonstrating compliance.
- Parallel review: implemented processes analysis involved multiple auditors with specialized expertise in key regulatory areas, including Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and Good Pharmacovigilance Practice (GVP). These auditors conducted concurrent evaluations of the processes under scrutiny. Subsequently, they synthesized their observations to produce the most thorough and cohesive overview attainable.
- Electronic systems: to facilitate key audit activities, including interviews with subject matter experts, activities were conducted via Microsoft Teams and system demonstrations delivered through Microsoft Teams screen sharing. Essential documents were reviewed by granting the auditor access to the electronic Trial Master File (eTMF) system. Additionally, requested documents were securely shared with the auditor via dedicated SharePoint folders or web portals.
Success Factors and Outcome
Following the assessment, Arithmos delivered a detailed audit report outlining the global systems and processes reviewed, the methodology applied, and observations and recommendations to sustain compliance at both global and local levels.
The assessment concluded that, following implementation of appropriate corrective and preventive actions (CAPA), the Quality Management System would maintain alignment with GxP guidelines and relevant international regulatory expectations.
Key contributors to success included:
Auditor flexibility: Our auditors are equipped to support audits across all time zones and have successfully conducted remote audits across multiple regions.
Global expertise: Our team includes SMEs across all GxP areas, with experience conducting audits across the UK, EU, US, Australia, Japan, China, and other regions.
Detail-oriented methodology: Structured interviews and comprehensive planning generated granular insights and a clear view of alignment and discrepancies between global and local processes—enabling targeted remediation through CAPA.
Conclusion
This case study highlights the critical role of QMS assessments in supporting GxP compliance, sponsor oversight, and operational consistency across global clinical and quality organizations.
Key Services Offered
Arithmos Quality Services provides a comprehensive range of GxP audit and consultancy services designed to safeguard patient safety, protect data integrity, and support inspection readiness. These services enable organizations to:
Evaluate GCP compliance across service providers and clinical sites
Identify and remediate compliance gaps in processes and documentation, including targeted QMS improvement initiatives
Evaluate and integrate different quality systems and processes (QMS integration)
Develop and execute effective corrective and preventive actions (CAPA) following audits and assessments
Prepare for regulatory inspections through internal audits, external audits, and mock inspections
Deliver specialist training on GxP regulations and key topics such as sponsor oversight, serious breaches, and electronic system assessments
Why Partner with Arithmos?
Pharma sponsors face mounting pressures to ensure trial integrity, GCP compliance, and timely regulatory submissions amid complex global supply chains. Our firm delivers unparalleled value through a structured approach tailored to sponsor needs, safeguarding your investments and expediting development milestones.
Proven Experience in Global and Local QMS Assessments Across All GxP Areas
Our track record includes successful delivery of Quality Management System (QMS) assessments for multinational organizations, spanning GMP, GCP, GLP, and GVP. This extensive experience ensures comprehensive coverage of regulatory nuances, from site-specific audits to enterprise-wide programs, reducing compliance gaps and accelerating market access.
Auditors with Hands-On Regulatory Inspection and Industry Experience
Our auditors bring direct experience from regulatory inspections combined with deep industry roles in pharmaceuticals and CROs. This insider perspective enables precise identification of vulnerabilities others might overlook, fostering trust and yielding actionable insights that withstand scrutiny.
Pragmatic, Risk-Based Recommendations Aligned to Regulatory Expectations
We provide tailored, prioritized recommendations grounded in ICH guidelines and risk-assessment frameworks, avoiding one-size-fits-all solutions. Clients benefit from enhanced CAPA effectiveness, streamlined remediation, and sustained compliance without unnecessary resource drain.
Flexible Delivery Model, Including Fully Remote Global Assessments
Our scalable model supports on-site, hybrid, or fully remote engagements via secure digital platforms, accommodating global teams across time zones. This minimizes disruption, controls costs, and ensures uninterrupted service for distributed operations.
By choosing our services, companies gain a strategically committed to excellence, backed by real-world results and adaptability in an evolving regulatory environment.
About the Author
GVP & GCP Associate Director | GxP Consultant & Auditor
Andrea Pucci joined Arithmos in 2023 and currently serves as Associate Director for GCP and GVP, overseeing auditing activities in these domains while managing Arithmos auditors and consultants.
Previously, he spent a decade as QA Director at CROS NT, an Italian CRO, where he directed quality assurance operations. Before that, as Quality Assurance Manager at Sigma Tau, a Global Pharma Company, he contributed to clinical development by conducting audits of study documentation, CROs, central labs, and clinical sites; planning and executing system audits for the Clinical Development group; and leading the training program for clinical staff as training manager.
With over 20 years as a seasoned auditor, Andrea specializes in clinical trials and trial data management, delivering precise compliance across U.S., EU, and UK regulations, including GDPR frameworks.
Currently, he is Associate Director GCP&GVP and leads QA Consultancy and auditing services for multinational firms, ensuring robust data governance, comprehensive risk assessments, and regulatory alignment.
About Arithmos
With deep expertise in the Life Science Industry, Arithmos supports companies in their digital transformation journey to achieve the best value from technology-enabled solutions and excellence in business operations.
Arithmos team share extensive knowledge of the full GxP regulated environment for both deliveries of services and technologies, and our domains range from Clinical Development, Quality & Compliance, Pharmacovigilance & Safety and, Regulatory Affairs.
